Electrophysiological Characteristics of Atrial Fibrillation Trigger Sites During Ongoing Atrial Fibrillation Using Ultra‐High‐Resolution Mapping Authors: Kohki Nakamura, Takehito Sasaki, Taiki Masuyama, Kentaro Minami, Shingo Yoshimura, Suguru Nishiuchi, Akiko Kodama, Kojiro Hattori, Kenichi Kaseno, Nobusada Funabashi, Shigeto Naito Published: 2026 ABSTRACT ABSTRACTIntroductionAtrial fibrillation (AF) triggers are commonly identified at the onset of AF, but the electrophysiological behavior of trigger sites during ongoing AF remains incompletely understood. This study aimed to characterize local electrogram properties at AF trigger sites during ongoing AF using an ultra‐high‐resolution mapping system.Methods and ResultsWe retrospectively studied 45 consecutive patients with pulmonary vein (PV) or superior vena cava (SVC) triggers who underwent mapping during ongoing AF. The local cycle length (L‐CL) and the proportion of the activation duration within the L‐CL (duty cycle, DC) were assessed using an automated mapping tool (Ockham, Boston Scientific) and were compared among trigger veins, non‐trigger PVs, the left atrium (LA), non‐trigger SVC, and the right atrium (RA). A total of 56 AF triggers were documented. Trigger veins exhibited a significantly shorter minimum L‐CL than the non‐trigger PVs, LA, non‐trigger SVC, and RA (median, 119, 129, 131, 157, and 139 ms, respectively; p < 0.0001). The quartiles and maximum L‐CL values and all DC parameters were comparable among the trigger veins, non‐trigger PVs, and LA. A receiver operating characteristic analysis demonstrated that the minimum L‐CL had the strongest association with trigger sites (area under the curve, 0.856).ConclusionAF trigger sites were characterized by a markedly shorter minimum L‐CL during ongoing AF, suggesting transient rapid activity. These findings provide mechanistic insights into the electrophysiological behavior of AF trigger sites and may offer complementary information when conventional trigger mapping is inconclusive.Keywords: atrial fibrillation, catheter ablation, local cycle length, trigger, ultra‐high‐resolution mapping Introduction Triggers of atrial fibrillation (AF) are critical targets for AF catheter ablation, with the pulmonary veins (PVs) being the main source [1]. Nevertheless, accurate localization of AF triggers remains challenging in clinical practice, particularly when triggers are infrequent, non‐reproducible, or arise from multiple sites simultaneously. Previous studies have primarily focused on electrophysiological characteristics at the onset of AF, where trigger sites are identified by the earliest activation followed by rapid repetitive activity [2, 3, 4, 5]. In contrast, the electrophysiological behavior of trigger sites during ongoing AF has not been well characterized. Recent advances in high‐density and high‐resolution mapping technologies have enabled detailed characterization of local electrograms during AF [6]. The Ockham software module (Boston Scientific, Marlborough, MA) enables automated assessment of local cycle length (L‐CL), the proportion of the activation duration within the L‐CL (duty cycle, DC), and electrogram consistency. These parameters have been proposed to identify regions with rapid and repetitive activity during AF, potentially corresponding to AF drivers [7]. However, their relationship to AF trigger sites remains unclear. The present study aimed to characterize local electrogram properties at trigger sites during ongoing AF using an ultra‐high‐resolution mapping system. By comparing those properties across trigger and non‐trigger regions, we sought to determine whether trigger sites exhibit distinct features during ongoing AF and to explore their potential mechanistic role in AF dynamics. Methods Study Population We retrospectively studied 45 consecutive patients who had AF triggers originating from the PVs or superior vena cava (SVC) and underwent mapping during ongoing AF in the PVs, SVC, and both atria using the Ockham software module of the Rhythmia mapping system during AF catheter ablation at Gunma Prefectural Cardiovascular Center between June 2024 and December 2024. The exclusion criteria were (1) the absence of reproducible induction of AF triggers, (2) the inability to perform mapping during ongoing AF due to spontaneous AF termination, or (3) the presence of triggers originating from sites other than the PVs and SVC. Consequently, 45 patients with AF triggers originating from the PVs or SVC were analyzed. This study was conducted in accordance with the Declaration of Helsinki and approved by the institutional ethics committee. An opt‐out method was applied to obtain consent from the study patients. AF Catheter Ablation All patients received deep sedation throughout the ablation procedure using propofol and/or dexmedetomidine with pentazocine. Oral anticoagulants were continued throughout the periprocedural period, and the activated clotting time was maintained between 300 and 400 s by a bolus and continuous heparin infusion during the ablation procedure [1]. A multielectrode catheter was positioned in the coronary sinus (CS) via the right femoral vein. Two or three transseptal sheaths were introduced into the left atrium (LA) via a single transseptal puncture. Mapping of AF triggers was performed using a radiofrequency ablation (RFA) or pulsed field ablation (PFA) catheter, mini‐basket catheter (IntellaMap Orion, Boston Scientific), and circular mapping catheter, while mapping during ongoing AF was performed exclusively using the mini‐basket catheter. AF Trigger Mapping AF trigger mapping was performed using a predefined stepwise protocol applied uniformly across all patients. The origin of AF triggers was defined as the site with the earliest local activation at the onset of AF in a reproducible manner, confirmed by repeated AF initiation [2, 3, 4, 5]. Triggers were initially mapped while multiple ablation and mapping catheters were positioned in the PVs, starting with the left PVs (LPVs), followed by the right PVs (RPVs). If extra‐PV triggers were suspected, those ablation and mapping catheters were sequentially repositioned to the LA, and then to the right atrium (RA) and SVC. AF triggers were identified (1) at baseline, (2) during high‐dose isoproterenol infusion, and (3) after electrical cardioversion of AF induced by triggers or atrial burst pacing during isoproterenol infusion [4, 5, 8]. In patients who were in sinus rhythm at the beginning of mapping, if no spontaneous triggers occurred at baseline, isoproterenol was administered intravenously up to 20 μg/min. If triggers were still absent, AF was induced by atrial burst pacing with a cycle length of up to 150 ms, followed by electrical cardioversion. This sequence of AF induction and cardioversion was repeated multiple times to confirm the reproducibility of AF initiation and to consistently identify the earliest activation site. In patients who were in AF at the beginning of mapping, AF was electrically cardioverted. If no spontaneous triggers occurred after cardioversion, the same protocol used for patients in sinus rhythm was applied. AF Mapping The PVs, SVC, and both atria were mapped during ongoing AF using the Ockham software module in all patients. That module provides three primary electrogram‐based metrics recorded by the mini‐basket catheter during AF: electrogram consistency, L‐CL, and DC [7]. Consistency reflects the repetitiveness of electrogram morphology across consecutive beats and electrodes, as determined by the software algorithm. L‐CL is derived from activation intervals across all 64 electrograms on the mini‐basket catheter over three consecutive beats, as defined by the default algorithm of the module. The measurable range of L‐CL is predefined by the system between 115 ms and 305 ms. DC represents the proportion of L‐CL occupied by electrogram activity across all splines of the mini‐basket catheter and ranges from 0% to 100%. A consistency threshold of 0.6, corresponding to the default setting of the module, was applied uniformly across all patients. Only electrograms with a consistency ≥ 0.6 were included in the analysis. L‐CL and DC values were collected from all eligible electrograms within each anatomical region. All parameters were automatically generated by the software without manual annotation. Ablation Strategy After mapping of triggers and ongoing AF, PV isolation (PVI) was performed in patients undergoing an initial AF ablation procedure and those undergoing a redo AF ablation procedure with PV reconnections. During RFA‐based PVI, an externally irrigated ablation catheter capable of contact force (CF)‐sensing and local impedance (LI)‐monitoring (IntellaNav StablePoint, Boston Scientific) was used. Circumferential lesions encircling the ipsilateral superior and inferior PVs were created by a point‐by‐point ablation technique with an inter‐lesion distance of ≤ 5 mm [9, 10]. RF energy was delivered with a target CF of 5‐20 g and power output of 50 W away from the esophagus and ≤ 40 W near the esophagus. Esophageal temperature was monitored, and RF delivery was interrupted when the temperature reached 41 degrees Celsius. During PFA‐based PVI, at least eight applications per PV were delivered at the PV ostium or antrum using a fixed‐loop or 31‐mm pentaspline PFA catheter (PulseSelect, Medtronic Inc., Minneapolis, MN or FARAWAVE, Boston Scientific) [11, 12, 13]. Additional applications within the PVs or on the carina region were delivered at the operator's discretion. If SVC triggers were identified, the SVC was electrically isolated using an RFA catheter. Additional ablation was performed at the operator's discretion after completing PVI and/or SVC isolation. Localization of AF Triggers and Local Electrogram Analysis The origin of AF triggers was categorized into six regions: left superior PV (LSPV), left inferior PV (LIPV), left common PV (LCPV), right superior PV (RSPV), right inferior PV (RIPV), and SVC (Figure 1). The LCPV was regarded as a single vein. The atrial and venous anatomy was determined based on the geometry created by the mini‐basket catheter, which was integrated with the three‐dimensional computed tomography or magnetic resonance imaging reconstructions. The PVs and LA were segmented at the level of each PV antrum, corresponding to the estimated PVI lines. The SVC and RA were segmented at the RA‐SVC junction. Schematic representations of the segmentation of the PVs and LA in the posteroanterior view (left panels) and the SVC and RA in the anteroposterior view (right panel). The PVs and LA were segmented at the level of the PV antrum, and the SVC and RA were segmented at the level of the RA‐SVC junction (black dotted lines). IVC, inferior vena cava; LA, left atrium; LAA, LA appendage; LCPV, left common pulmonary vein (PV); LIPV, left inferior PV; LSPV, left superior PV; RIPV, right inferior PV; RSPV, right superior PV; RA, right atrium; RAA, RA appendage; SVC, superior vena cava; TA, tricuspid annulus. To evaluate the relationship between the presence of triggers and local electrogram properties during ongoing AF, the PVs and SVC were categorized as trigger veins or non‐trigger veins. Trigger veins were defined as PVs or the SVC with documented triggers, while non‐trigger veins were defined as those without. Scatter plots for the L‐CL and DC were created for each anatomical region, including PVs and the SVC, LA, and RA. The minimum, first quartile (Q1, 25th percentile), second quartile (Q2, median), third quartile (Q3, 75th percentile), and maximum values of the L‐CL and DC were compared among five groups: trigger veins, non‐trigger PVs, LA, non‐trigger SVC, and RA. Post‐Ablation Follow‐Up The study patients were followed up in the outpatient clinics every 1 to 3 months. Follow‐up examinations including a 12‐lead electrocardiogram (ECG), 24 h Holter monitoring, and ambulatory ECG monitoring were performed at each follow‐up visit or emergency visit for any symptoms including palpitations, chest discomfort, or dizziness. Any episodes of atrial tachyarrhythmias lasting more than 30 s after a 90‐day blanking period were regarded as atrial tachyarrhythmia recurrences. Any symptoms lasting more than 30 s even without ECG recordings, which were similar to those during the AF before ablation, were also regarded as arrhythmia recurrences. The decision to continue or discontinue antiarrhythmic drugs was left up to the patient's preference and discretion of the physician in charge. Statistical Analysis Continuous variables were expressed as the mean ± standard deviation (SD) or median and interquartile range (IQR), and categorical variables were the number and percentage of patients. A comparative analysis of the L‐CL and DC among the trigger veins, non‐trigger PVs, LA, non‐trigger SVC, and RA was performed using the Kruskal‐Wallis test with the Steel‐Dwass post hoc test. To compare the strength of the association of the local electrogram properties for predicting the presence of triggers, the area under the receiver operating characteristic (ROC) curve for each parameter was estimated. A p value of < 0.05 was considered statistically significant. The statistical analyses were performed using SPSS Statistics, version 22 (IBM Corporation, Armonk, NY) and JMP, version 11.2 (SAS Institute Inc., Cary, NC). Results The baseline characteristics of the study population are summarized in Table 1. Nineteen patients (42.2%) had non‐paroxysmal AF. Three patients (6.7%) had undergone previous AF ablation procedures limited to PV isolation, with or without cavotricuspid isthmus ablation. Two patients had an LCPV, three had all PVs already isolated with previous ablation procedures, and one underwent mapping of triggers and ongoing AF after an RPV isolation because spontaneous triggers originating from the LSPV and subsequent sustained AF did not occur until the RPVs had been isolated. Thus, a total of 164 PVs, including 82 LPVs and 82 RPVs, were analyzed. The SVC, LA, and RA were analyzed in all patients. Three patients continued bepridil during the periprocedural period, while the remaining patients discontinued antiarrhythmic drugs for at least five half‐lives before the ablation. TABLE 1Baseline characteristics of the study population.Number of patients45Age (years)68 ± 9Male sex33 (73.3)Body weight (kg)66.3 ± 9.8Body mass index (kg/m2)23.9 ± 3.0Type of AFParoxysmal26 (57.8)Non‐paroxysmal19 (42.2)Structural heart disease* 5 (11.1)Ischemic heart disease4Hypertrophic cardiomyopathy0Dilated cardiomyopathy0Moderate–severe valvular disease1Tachycardia‐induced cardiomyopathy2Hypertension19 (42.2)Diabetes mellitus9 (20.0)Heart failure5 (11.1)Stroke/transient ischemic attack1 (2.2)CHA2DS2‐VASc score2 (1–3)Creatinine (mg/dL)0.88 (0.77–1.05)eGFR (mL/min/1.73m2)61 ± 14BNP (pg/mL)57.1 (22.5–157.1)Transthoracic echocardiographic findingsLA diameter (mm)39 ± 5Left ventricular ejection fraction (%)65 (60–65)CT or MR imaging findingsLA volume (mL)108.8 (92.6–134.6)LA volume index (mL/m2)63.9 (55.1–74.0)Left common PV2 (4.4)Number of previous LA ablation procedures042 (93.3)≥ 13 (6.7)Medical therapy before admissionWarfarin0Direct oral anticoagulants45 (100)Class I antiarrhythmic drugs9 (20.0)Amiodarone1 (2.2)Bepridil5 (11.1) Note: Data are given as the mean ± SD, median (IQR), or number (%).Abbreviations: AF, atrial fibrillation; BNP, B‐type natriuretic peptide; CHA2DS2‐VASc score, congestive heart failure, hypertension, diabetes mellitus, vascular disease (myocardial infarction, aortic plaque, and peripheral vascular disease), an age of 65–74 years, a female gender (1 point for the presence of each), an age ≥ 75 years, and a stroke and transient ischemic attack (2 points); CT, computed tomography; eGFR, estimated glomerular filtration rate; LA, left atrial; MR, magnetic resonance.*Two patients had multiple structural heart diseases. Baseline characteristics of the study population. Note: Data are given as the mean ± SD, median (IQR), or number (%). Abbreviations: AF, atrial fibrillation; BNP, B‐type natriuretic peptide; CHA2DS2‐VASc score, congestive heart failure, hypertension, diabetes mellitus, vascular disease (myocardial infarction, aortic plaque, and peripheral vascular disease), an age of 65–74 years, a female gender (1 point for the presence of each), an age ≥ 75 years, and a stroke and transient ischemic attack (2 points); CT, computed tomography; eGFR, estimated glomerular filtration rate; LA, left atrial; MR, magnetic resonance. Two patients had multiple structural heart diseases. Table 2 presents the procedural characteristics during the current ablation procedure. A PVI was completed or verified in all patients, and additional LA ablation was performed in 12 patients (26.7%). An SVC isolation was performed in seven patients (15.6%), including four patients with documented SVC triggers and three who underwent empirical SVC isolation. Procedure‐related complications occurred in three patients (6.7%), including one atherothrombotic cerebral infarction, one transient gastric hypomotility, and one femoral groin hematoma. TABLE 2Procedural characteristics during the current ablation procedure.Total procedure time (min)129 (111–148)Total fluoroscopic time (min)33 (28–49)RFA only (n = 22)Total number of RFA applications82 (71–93)Total RFA duration (min)26.9 ± 9.4Total RF energy delivery (×103 J)75.9 ± 32.0PFA with or without additional RFA (n = 23)* Total number of PFA applications54 ± 8Total number of RFA applications12 (9–24)Total RFA duration (min)12.8 ± 9.1Total RF energy delivery (×103 J)27.2 ± 10.7Ablation procedurePVI42 (93.3)SVC isolation7 (15.6)LA roof linear ablation11 (24.4)LA floor linear ablation6 (13.3)Anterior LA linear ablation0Lateral mitral isthmus linear ablation0CTI ablation31 (68.9)AT ablation1 (2.2)Complications** 3 (6.7)Cardiac tamponade0Stroke1Coronary artery spasm0Air embolism0Gastric hypomotility1Pseudoaneurysm0Groin hematoma1 Note: Data are given as the mean ± SD, median (IQR), or number (%). The other abbreviation is as in Table 1.Abbreviations: AT, atrial tachycardia; CTI, cavotricuspid isthmus; PFA, pulsed field ablation; PVI, pulmonary vein (PV) isolation; RF, radiofrequency; RFA, RF ablation; SVC, superior vena cava.*Sixteen patients underwent both PFA and RFA, and the remaining seven underwent PFA alone.**Gastric hypomotility occurred after the RFA procedure, and a stroke and groin hematoma occurred after the PFA procedures. Procedural characteristics during the current ablation procedure. Note: Data are given as the mean ± SD, median (IQR), or number (%). The other abbreviation is as in Table 1. Abbreviations: AT, atrial tachycardia; CTI, cavotricuspid isthmus; PFA, pulsed field ablation; PVI, pulmonary vein (PV) isolation; RF, radiofrequency; RFA, RF ablation; SVC, superior vena cava. Sixteen patients underwent both PFA and RFA, and the remaining seven underwent PFA alone. Gastric hypomotility occurred after the RFA procedure, and a stroke and groin hematoma occurred after the PFA procedures. Distribution of AF Triggers A total of 56 AF triggers were identified, including 24 LSPVs, 13 LIPVs, 2 LCPVs, 9 RSPVs, 4 RIPVs, and 4 SVCs (Figure S1). All triggers were eliminated by PVI or SVC isolation. Representative cases with PV and SVC triggers are shown in Figure 2 and Figure 3. A representative case with LSPV and LIPV triggers. (A) Whole‐region mapping of the PVs, LA, SVC, and RA is shown. Bipolar voltage maps and scatter plots of the L‐CL and DC are presented for the PVs and LA (upper pairs of panels) and for the SVC and RA (lower pairs of panels) in the posteroanterior (left panels) and anteroposterior (right panels) views. When the Ockham software module was set to highlight areas with an L‐CL of 115–125 ms, highlighted areas were observed in the posterior LSPV and LIPV (white arrowheads), whereas no highlighted areas were observed in the RSPV, RIPV, LA, SVC, or RA. (B) Twelve‐lead and intracardiac electrocardiograms at AF onset induced by triggers originating from the LSPV (left panel) and LIPV (right panel) are shown (red arrowheads). (C) Local electrograms recorded by the mini‐basket catheter at sites with the minimum L‐CL within each segmented anatomical region (left panels), corresponding bipolar voltage maps (middle panels), and scatter plots of the L‐CL and DC (right panels). To demonstrate the minimum L‐CL within each region, Panel C selectively displays the anatomical region used for calculation of the minimum, quartile, and maximum L‐CL and DC values. The Ockham software module highlighted the sites with the minimum L‐CL within each segmented region (white arrows). In the bipolar voltage maps, low‐voltage and scar areas were defined as areas with bipolar electrogram amplitudes of < 0.5 mV and < 0.1 mV, respectively. In the scatter plots, the horizontal and vertical axes represent L‐CL and DC, respectively, and the L‐CLs highlighted in green correspond to the areas highlighted on the maps. C, consistency; CS, coronary sinus recording; DC, duty cycle; L‐CL, local cycle length; MA, mitral annulus. The other abbreviations are as in Figure 1. A representative case with an SVC trigger. (A) Whole‐region mapping of the PVs, LA, SVC, and RA is shown. Bipolar voltage maps and scatter plots of the L‐CL and DC are presented for the PVs and LA (upper pairs of panels) and for the SVC and RA (lower pairs of panels) in the posteroanterior (left panels) and anteroposterior (right panels) views. When the Ockham software module was set to highlight areas with an L‐CL of 115–120 ms, a highlighted area was observed in the septal SVC (white arrowhead), whereas no highlighted areas were observed in the PVs, LA, or RA. (B) Twelve‐lead and intracardiac electrocardiograms at AF onset induced by a trigger originating from the SVC are shown (red arrowhead). (C) Local electrograms recorded by the mini‐basket catheter at sites with the minimum L‐CL within each segmented anatomical region (left panels), corresponding bipolar voltage maps (middle panels), and scatter plots of the L‐CL and DC (right panels). To demonstrate the minimum L‐CL within each region, Panel C selectively displays the anatomical region used for calculation of the minimum, quartile, and maximum L‐CL and DC values. The Ockham software module highlighted the sites with the minimum L‐CL within each segmented region (white arrows). In the bipolar voltage maps, low‐voltage and scar areas were defined as areas with bipolar electrogram amplitudes of < 0.5 mV and < 0.1 mV, respectively. In the scatter plots, the horizontal and vertical axes represent L‐CL and DC, respectively, and the L‐CLs highlighted in green correspond to the areas highlighted on the maps. The abbreviations are as in Figure 1 and Figure 2. Local Electrogram Properties During Ongoing AF During mapping of ongoing AF, whole‐region mapping of the PVs, LA, SVC, and RA was performed in all patients. The median number of electrograms acquired per patient was 1609 (IQR, 1206–2421), including 760 (IQR, 605–1266) in the PVs, 515 (IQR, 374–768) in the LA, 76 (IQR, 41–99) in the SVC, and 268 (IQR, 118–409) in the RA. The median values of the minimum, first quartile (Q1), median (Q2), third quartile (Q3), and maximum L‐CL were 118 ms (IQR, 117–124 ms), 149 ms (IQR, 143–161 ms), 160 ms (IQR, 152–173 ms), 176 ms (IQR, 168–184 ms), and 257 ms (IQR, 237–280 ms), respectively, while those of the DC were 21% (IQR, 19%–25%), 57% (IQR, 53%–62%), 71% (IQR, 65%–76%), 86% (IQR, 81%–92%), and 100% (IQR, 100%–100%), respectively. Table 3 presents the comparison of the L‐CL and DC among the PVs, LA, SVC, and RA. Both parameters were comparable between the PVs and LA, while the L‐CL tended to be shorter and the DC tended to be higher in the PVs and LA than in the SVC and RA. TABLE 3Comparison of the L‐CL and DC among the PVs, LA, SVC, and RA.VariablePVsLASVCRA p L‐CL (ms)Minimum126 (119–135)131 (124–136)155 (143–172) ** , †† , ‡‡ 139 (130–148) ** , † < 0.000125th percentile148 (140–158)150 (145–160)177 (164–193) ** , †† , ‡‡ 161 (150–171)** < 0.0001Median157 (147–168)160 (152–171)186 (174–205) ** , †† , ‡‡ 170 (157–182)** < 0.000175th percentile167 (156–178)168 (160–182)204 (185–220) ** , †† , ‡‡ 182 (167–193) ** , † < 0.0001Maximum198 (187–221)204 (193–225)245 (223–279) ** , †† 235 (214–251) ** , †† < 0.0001DC (%)Minimum32 (26–36)30 (27–34)26 (21–33)* 31 (25–36)0.036425th percentile59 (53–64)61 (54–66)47 (41–56) ** , †† , ‡‡ 55 (48–60) * , † < 0.0001Median73 (67–79)74 (66–80)61 (53–69) ** , †† 68 (59–74) ** , † < 0.000175th percentile88 (82–94)90 (80–94)77 (67–82) ** , †† 80 (73–89) ** , † < 0.0001Maximum100 (99–100)100 (100–100)99 (93–100) ** , †† , ‡‡ 100 (99–100)< 0.0001 Note: Data are given as the median (IQR). The other abbreviations are as in Tables 1 and 2.Abbreviations: DC, duty cycle; L‐CL, local cycle length; RA, right atrium.* p < 0.05.**Significantly different from the PVs at p < 0.01. † p < 0.05. †† Significantly different from the LA at p < 0.01. ‡ p < 0.05. ‡‡ Significantly different from the RA at p < 0.01. Comparison of the L‐CL and DC among the PVs, LA, SVC, and RA. Note: Data are given as the median (IQR). The other abbreviations are as in Tables 1 and 2. Abbreviations: DC, duty cycle; L‐CL, local cycle length; RA, right atrium. p < 0.05. Significantly different from the PVs at p < 0.01. p < 0.05. Significantly different from the LA at p < 0.01. p < 0.05. Significantly different from the RA at p < 0.01. Relationship Between AF Triggers and Local Electrogram Properties During Ongoing AF Figure 4 shows the comparison of the L‐CL and DC among the trigger veins, non‐trigger PVs, LA, non‐trigger SVC, and RA. The minimum L‐CL in the trigger veins was significantly shorter than that in the non‐trigger PVs, LA, non‐trigger SVC, and RA (119 ms [IQR, 118–125 ms], 129 ms [IQR, 121–142 ms], 131 ms [IQR, 124–136 ms], 157 ms [IQR, 147–174 ms], and 139 ms [IQR, 130–148 ms], respectively; p < 0.0001). In contrast, the quartiles and maximum L‐CL values and all DC parameters were comparable among the trigger veins, non‐trigger PVs, and LA. Comparison of the (A) L‐CL and (B) DC among the trigger veins, non‐trigger PVs, LA, non‐trigger SVC, and RA. In the box‐and‐whisker plots, the center line indicates the median, the box represents the IQR, the whiskers indicate the range excluding outliers, and the circles represent outliers. (C) The table shows the minimum, quartile, and maximum values of the L‐CL and DC in the trigger veins, non‐trigger PVs, LA, non‐trigger SVC, and RA, respectively. **Significantly different from the trigger veins at p < 0.01, *p < 0.05. ††Significantly different from the non‐trigger PVs at p < 0.01, †p < 0.05. ‡‡Significantly different from the LA at p < 0.01, ‡p < 0.05. §§Significantly different from the RA at p < 0.01, §p < 0.05. The abbreviations are as in Figure 1 and Figure 2. An ROC analysis demonstrated that the minimum L‐CL exhibited a larger area under the curve (AUC) than the other parameters, and the AUC for the minimum L‐CL was 0.856 (95% confidence interval [CI], 0.811–0.901) (Figure 5). According to the results of the ROC analyses, the sensitivity and specificity for predicting the presence of triggers were 96.4% and 61.6%, respectively, at an optimal cutoff of ≤ 130 ms for the minimum L‐CL. Association of the L‐CL and DC with AF trigger sites. The upper panels represent the ROC curves for the (A) L‐CL and (B) DC. The dots on the ROC curves indicate the optimal cutoffs. (C) The table shows the AUC with a 95% CI, optimal cutoff, sensitivity, specificity, and positive and negative predictive values for the minimum, quartile, and maximum values of the L‐CL and DC. Abbreviations: AUC, area under the curve; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value. The other abbreviations are as in Figure 2. Additional subgroup analyses according to trigger origin were performed to evaluate the potential influence of the predominance of LSPV triggers. Two LCPV triggers were grouped with LSPV triggers for this analysis. The minimum L‐CL did not significantly differ among LSPV/LCPV, LIPV, RSPV, RIPV, and SVC triggers (p = 0.998). In addition, the minimum L‐CL was comparable between LSPV/LCPV and non‐LSPV/LCPV triggers (119 [118–125] ms vs. 119 [117–125] ms, p = 0.818) (Figure S2). Clinical Outcomes During a median follow‐up period of 386 days (IQR, 369–429 days), one patient experienced an AF recurrence (Figure S3). Antiarrhythmic drugs were continued at the final follow‐up in two patients (4.4%). Discussion Major Findings This retrospective observational study investigated local electrogram properties during ongoing AF in the PVs and SVC with AF triggers using an ultra‐high‐resolution mapping system. The main findings were as follows: (1) the trigger veins exhibited a significantly shorter minimum L‐CL than the non‐trigger regions; (2) the quartiles and maximum L‐CL values and all DC parameters were comparable among the trigger veins, non‐trigger PVs, and the LA; and (3) the minimum L‐CL demonstrated the strongest association with AF trigger sites. Mechanistic Interpretation of Shorter Minimum Cycle Length The present study demonstrated that only the minimum L‐CL, rather than other L‐CL parameters or DC, distinguished trigger from non‐trigger regions. This finding suggests that AF trigger sites may exhibit transient rapid activity during ongoing AF rather than sustained rapid activation. Previous studies have reported that AF triggers are characterized by the earliest activation at AF onset, followed by rapid repetitive activity [3, 4, 5, 8]. However, such activity does not necessarily persist continuously during ongoing AF [3]. This may explain why the quartiles and maximum L‐CL values did not significantly differ between the trigger and non‐trigger PVs. Our results provide new insights into the electrophysiological behavior of AF trigger sites during ongoing AF and suggest that transient rapid activity, rather than sustained rapid activation, may characterize trigger regions. Relationship Between AF Triggers and Drivers The Ockham software module has been reported to identify potential AF driver regions characterized by shorter L‐CLs and higher DC values than surrounding areas [7]. In contrast, the present study demonstrated that trigger sites were primarily characterized by a shorter minimum L‐CL without significant differences in the DC. This discrepancy may reflect differences between AF triggers and drivers. AF drivers typically exhibit sustained, spatio‐temporally consistent rapid activity, whereas AF triggers may demonstrate intermittent rapid discharges. Thus, AF trigger sites during ongoing AF may exhibit transient acceleration rather than sustained driver‐like behavior. We speculated that AF triggers and drivers may share certain electrophysiological features but differ in their temporal stability. Cycle Length Measurements During AF Previous studies have suggested that shorter cycle lengths during AF may represent potential ablation targets [3, 14, 15, 16, 17, 18, 19]. However, conventional methods of determining cycle lengths have several limitations. First, cycle lengths are typically calculated as averages over multiple beats, which are usually measured manually, making the process subjective and potentially lacking in reproducibility. Second, averaged cycle lengths may obscure transient rapid activity. Third, conventional methods cannot evaluate cycle lengths across the entire atria, PVs, and SVC because cycle length measurements are performed at specific sites using regional mapping. In contrast, the Ockham software module automatically calculates L‐CLs based on three consecutive beats, allowing detection of transient short cycle lengths and enabling comprehensive evaluation across the atria, PVs, and SVC. This approach may be particularly suitable for identifying intermittent rapid activity that characterizes AF trigger sites. Clinical Implications Although PVI remains the cornerstone of AF ablation, accurate localization of AF triggers remains challenging, particularly when triggers are infrequent, non‐reproducible, or arise from multiple sites. The mapping approach used in the present study is not intended to replace conventional mapping of AF triggers based on the earliest activation at AF onset, which remains the standard method for identifying AF trigger sites. Rather, ultra‐high‐resolution mapping during ongoing AF may provide complementary mechanistic information when conventional trigger mapping is inconclusive. The primary value of this approach may be the characterization of trigger‐associated electrophysiological features during sustained AF, rather than a reduction in the time required to identify AF trigger sites. This approach may also be relevant for extra‐PV/SVC triggers, although this requires validation in future studies. Therefore, the present findings should primarily be interpreted as mechanistic insights into the electrophysiological behavior of potential trigger sites during ongoing AF rather than direct guidance for ablation strategies. Study Limitations The present study has several limitations. First, this was a retrospective single‐center study with a relatively small sample size. Second, the study included only patients with PV and SVC triggers and did not evaluate extra‐PV/SVC triggers. Whether extra‐PV/SVC triggers exhibit similar local electrogram properties during ongoing AF as PV/SVC triggers remains unclear and warrants further investigation. Third, both spontaneous and induced AF episodes were analyzed, and the electrophysiological properties of induced AF may differ from those of spontaneous AF. In addition, provocation of AF triggers with adenosine triphosphate was not performed in the present study; therefore, the electrophysiological characteristics of adenosine‐sensitive triggers during ongoing AF remain unclear. Despite repeated induction protocols, it is possible that not all AF triggers were identified. The influence of far‐field potentials, particularly from the LA appendage on LSPV electrograms, cannot be completely excluded. Fourth, ablation strategies were not completely uniform across patients, reflecting real‐world clinical practice. Finally, the consistency threshold was fixed at 0.6, corresponding to the default threshold of the mapping module. Although this threshold enabled analysis of relatively reproducible electrogram activity, rapid activations with variable morphology may have been underestimated. The optimal consistency threshold for detecting trigger‐related transient rapid activity remains unknown, and different consistency thresholds may yield different results. Conclusions Among patients with AF triggers originating from the PVs or SVC, trigger veins exhibited a significantly shorter minimum L‐CL during ongoing AF than non‐trigger veins and the surrounding atrial regions, as assessed using an ultra‐high‐resolution mapping tool. The minimum L‐CL demonstrated the strongest association with the presence of AF triggers among all L‐CL‐ and DC‐related parameters. A markedly short minimum L‐CL during ongoing AF in the PVs and SVC may provide complementary information for identifying potential AF trigger sources. Author Contributions K.N. and S.N. designed the study. K.N., T.S., T.M., K.M., S.Y., S.N., A.K., K.H., and K.K. collected the data. K.N., T.S., and N.F. performed the statistical analyses. K.N. drafted the manuscript. K.N. and S.N. critically revised the manuscript. All authors read and approved the final version of the manuscript. Funding The authors have nothing to report. Ethics Statement This study was approved by the institutional ethics committee of Gunma Prefectural Cardiovascular Center (Approval number: 2024014) and adhered to the Declaration of Helsinki. An opt‐out approach was used for study participation. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Figure S1: Distribution of AF triggers. Values are presented as the number and percentage of veins with AF triggers. Figure S2: Comparison of the minimum L‐CL according to trigger origin. Figure S3: Kaplan–Meier curve for freedom from any atrial tachyarrhythmia recurrence after the ablation procedure. The arrhythmia‐free survival rate at the final follow‐up was 97.1%. Acknowledgments We would like to thank Mr. John Martin for his help in the preparation of the manuscript and Mr. Ryoya Takeuchi for his technical assistance with the measurement of the data. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Supplementary Materials Figure S1: Distribution of AF triggers. Values are presented as the number and percentage of veins with AF triggers. Figure S2: Comparison of the minimum L‐CL according to trigger origin. Figure S3: Kaplan–Meier curve for freedom from any atrial tachyarrhythmia recurrence after the ablation procedure. The arrhythmia‐free survival rate at the final follow‐up was 97.1%. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.